Pharmacogenetic Information in Clinical Guidelines: The European Perspective

Clin Pharmacol Ther. 2018 May;103(5):795-801. doi: 10.1002/cpt.1049. Epub 2018 Mar 30.

Abstract

Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx).1-3 In addition, patients are willing to consent to participate in PGx implementation studies.4 However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test.1,2 Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients.5,6.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Europe
  • Humans
  • Pharmacists / legislation & jurisprudence
  • Pharmacogenetics / legislation & jurisprudence*
  • Pharmacogenomic Testing / legislation & jurisprudence*
  • Physicians / legislation & jurisprudence